ClinVar Miner

Submissions for variant NM_007272.3(CTRC):c.760C>T (p.Arg254Trp) (rs121909293)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Illumina Clinical Services Laboratory,Illumina RCV000119045 SCV000349091 benign Hereditary pancreatitis 2018-03-06 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
Invitae RCV000119045 SCV000551759 association Hereditary pancreatitis 2020-10-06 criteria provided, single submitter clinical testing This sequence change replaces arginine with tryptophan at codon 254 of the CTRC protein (p.Arg254Trp). The arginine residue is moderately conserved and there is a moderate physicochemical difference between arginine and tryptophan. This variant is present in population databases (rs121909293, ExAC 2.3%). This variant is reported as heterozygous in ~2% of patients with chronic pancreatitis and in ~0.7% of unaffected controls; overall it has been reported to confer ~3-fold increased risk for chronic pancreatitis in heterozygous carriers (PMID: 18059268, 22942235, 22427236, 18172691, 25569187). ClinVar contains an entry for this variant (Variation ID: 8178). Experimental studies demonstrate that this missense change reduces the activity of CTRC by ~50% (PMID: 18059268). This result is consistent with increased trypsinogen activity in the pancreas and an increased risk for pancreatitis (PMID: 19453252). In summary, this missense variant affects protein function and is associated with a statistically significant risk for developing chronic pancreatitis. Therefore, it has been classified as an Increased Risk Allele.
ARUP Laboratories, Molecular Genetics and Genomics,ARUP Laboratories RCV000119045 SCV000603259 likely pathogenic Hereditary pancreatitis 2020-08-27 criteria provided, single submitter clinical testing The CTRC c.760C>T; p.Arg254Trp variant (rs121909293) has been reported in multiple individuals with chronic, hereditary, or recurrent acute pancreatitis, both in the homozygous state and in individuals carrying a second pathogenic variant (Beer 2013, Giefer 2017, Masamune 2013, Masson 2008, Rosendahl 2008, Rosendahl 2013). Functional characterization of p.Arg254Trp indicates a moderate reduction in the level of secreted CTRC protein, but no impact on enzymatic activity (Beer 2013, Rosendahl 2008), leading to its designation as a moderate-to-low-risk variant (Beer 2013). The variant is reported in ClinVar (Variation ID: 8178) and is found in the general population with an overall allele frequency of 0.46% (1305/282668 alleles, including 12 homozygotes) in the Genome Aggregation Database. However, it is reported to be at a higher frequency in affected European individuals compared to controls (Beer 2013, Masson 2008, Rosendahl 2008, Rosendahl 2013), and to co-occur at increased frequency with the SPINK1 p.Asn34Ser variant in affected individuals (Rosendahl 2008). The arginine at residue 254 is moderately conserved, and computational analyses predict that this variant is deleterious (REVEL: 0.809). Based on available information, this variant is considered to be likely pathogenic. References: Beer S et al. Comprehensive functional analysis of chymotrypsin C (CTRC) variants reveals distinct loss-of-function mechanisms associated with pancreatitis risk. Gut. 2013; 62(11):1616-24. Giefer MJ et al. Early-Onset Acute Recurrent and Chronic Pancreatitis Is Associated with PRSS1 or CTRC Gene Mutations. J Pediatr. 2017 Jul;186:95-100. LaRusch J et al. The Common Chymotrypsinogen C (CTRC) Variant G60G (C.180T) Increases Risk of Chronic Pancreatitis But Not Recurrent Acute Pancreatitis in a North American Population. Clin Transl Gastroenterol. 2015 Jan 8;6:e68. Masamune A et al. Identification of novel missense CTRC variants in Japanese patients with chronic pancreatitis. Gut. 2013; 62(4):653-4. Masson E et al. Association of rare chymotrypsinogen C (CTRC) gene variations in patients with idiopathic chronic pancreatitis. Hum Genet. 2008; 123(1):83-91. Rosendahl J et al. CFTR, SPINK1, CTRC and PRSS1 variants in chronic pancreatitis: is the role of mutated CFTR overestimated? Gut. 2013 Apr;62(4):582-92. Rosendahl J et al. Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis. Nat Genet. 2008; 40(1):78-82.
Ambry Genetics RCV001026619 SCV001189039 pathogenic Inborn genetic diseases 2019-03-06 criteria provided, single submitter clinical testing The p.R254W pathogenic mutation (also known as c.760C>T), located in coding exon 7 of the CTRC gene, results from a C to T substitution at nucleotide position 760. The arginine at codon 254 is replaced by tryptophan, an amino acid with dissimilar properties. This mutation has been shown to be over-represented in individuals with idiopathic or hereditary chronic pancreatitis; it was demonstrated to cause a reduction in chymotrypsin C activity due to decreased production and/or secretion (Rosendahl J et al. Nat Genet. 2008;40(1):78-82). <span style="background-color:initial">Another study found this mutation in 2.07% of affected individuals versus 0.57% of control individuals and in vitro<span style="background-color:initial"> studies suggest that this mutation results in slightly decreased protein secretion and increased rate of degradation by trypsin (Beer S et al. Gut<span style="background-color:initial">. 2013 Nov;62(11):1616-24). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation.
OMIM RCV000008657 SCV000028866 risk factor Pancreatitis, chronic, susceptibility to 2008-02-01 no assertion criteria provided literature only
GeneReviews RCV000119045 SCV000153751 pathogenic Hereditary pancreatitis 2014-03-13 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.